Prof. Yuanxi Huang 黄元夕
Chief Physician, Professor
Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Early diagnosis of breast cancer, neoadjuvant chemotherapy for locally advanced cases, postoperative chemotherapy and endocrine therapy, breast-conserving surgery, and minimally invasive surgical procedures.
Dr. Huang holds a medical degree from Harbin Medical University (1983–1989) and a PhD in Oncology. Dr. Huang completed postdoctoral research at Harbin Medical University (2008–2010). As Deputy Department Director and Professor, Dr. Huang has long worked in gastrointestinal tumor and breast surgery. Dr. Huang has published over 20 papers and received provincial science and technology awards.
Professional roles
- Member, Breast Cancer Professional Committee of Heilongjiang Province, China Anti-Cancer Association
- Professional Member, Biotherapy Committee of Heilongjiang Province, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Huang Yuanxi). Papers usually list the name as Yuanxi Huang or Huang Y.
Selected publications
30 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Heliyon, 2025 (senior author): Low expression of TOX predicts poor prognosis of patients with breast cancer in the real world: A retrospective study. PubMed 39758401
- Breast Cancer (Dove Med Press), 2024 (senior author): Transcription Factor Forkhead Box Protein 3 (FOXP3) as a Prognostic Indicator for Postoperative Outcomes in Patients with Breast Cancer: Establishment of a Prognostic Nomogram. PubMed 39464238
- Int J Med Sci, 2024 (senior author): The Gustave Roussy Immune score (GRIm score) as a novel prognostic score for early breast cancer patients: A real-world retrospective study. PubMed 39512692
- BMC Womens Health, 2024 (senior author): Development of predictive models for pathological response status in breast cancer after neoadjuvant therapy based on peripheral blood inflammatory indexes. PubMed 39395992
- Transl Oncol, 2024 (senior author): The prediction of pCR and chemosensitivity for breast cancer patients using DLG3, RADL and Pathomics signatures based on machine learning and deep learning. PubMed 38805774
- Oncology, 2024 (senior author): Clinicopathological Characteristics of Breast Cancer Patients with HER-2 Low Expression Receiving Neoadjuvant Therapy. PubMed 37669631
- J Cancer Res Clin Oncol, 2023 (senior author): Naples score: a novel prognostic biomarker for breast cancer patients undergoing neoadjuvant chemotherapy. PubMed 37698677
- World J Surg Oncol, 2023 (senior author): Prediction of nonsentinel lymph node metastasis in breast cancer patients based on machine learning. PubMed 37563717
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion